Prednisone Completed Phase 0 Trials for Dyslipidemias / Diabetes Mellitus (DM) / Atherosclerosis Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science0
clinicaltrials.gov IdentifierTitleDrugs
NCT03367663The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System.